Cofepris – New Regulatory Safety Strategy for Medical Devices

Cofepris Promotes New Regulatory Safety Strategy for Medical Devices

Cofepris (Federal Commission for the Protection against Health Risks) has launched a Regulatory Safety Strategy for medical devices, aimed at strengthening regulation and collaboration with companies in a market worth more than 16 billion dollars – Read more here

If you need more information on regulatory issues, ELS can certainly help with our wide range of services for your medical devices.

Contact your local ELS consultant or via email info@elssolutions.pt

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.